End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
88.03 CNY | -1.49% | -2.48% | -27.70% |
Apr. 24 | BMC Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 12 | BMC Medical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.70% | 780M | - | ||
+11.73% | 226B | B | ||
+9.53% | 188B | B- | ||
+14.63% | 137B | B- | ||
+27.47% | 108B | A- | ||
-0.04% | 63.19B | A- | ||
+13.73% | 52.26B | B+ | ||
+4.86% | 51B | B+ | ||
+7.72% | 43.89B | A | ||
+7.86% | 38.07B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 301367 Stock
- Ratings BMC Medical Co., Ltd.